Evaluation of Patients with Parkinson’s Disease in Intensive Care Units: A Cohort Study
Table 2
Univariate and multivariate analysis using death as a dependent variable.
Univariate analysis
OR (95% CI)
value
Parkinson’s disease
0.83 (0.55–1.25)
0.38
Lower level of consciousness on ICU admission
2.69 (1.76–4.09)
<0.001
VAD on ICU admission
5.81 (3.47–9.73)
<0.001
APACHE II in the first 24 hours in the ICU
1.17 (1.14–1.21)
<0.001
Multivariate analysis evaluating the influence of Parkinson’s disease on death
OR (95% CI)
value
Parkinson’s disease controlled by APACHE II score in the first 24 hours
0.70 (0.43–1.12)
0.138
Parkinson’s disease controlled by VAD on ICU admission
1.04 (0.68–1.59)
0.867
Parkinson’s disease controlled by lower level of consciousness on ICU admission
0.65 (0.42–1.00)
0.050
Parkinson’s disease controlled by VAD and lower level of consciousness on ICU admission
0.83 (0.53–1.29)
0.404
PD, Parkinson’s disease; VAD, vasoactive drug; ICU, intensive care unit; APACHE II, Acute Physiology and Chronic Health Evaluation. Odds ratio and 95% confidence interval of univariate logistic regression analysis, with a significance level of 5%. Odds ratio and 95% confidence interval of the multivariate logistic regression analysis, with a significance level of 5%.
